Fabrication and characterization of Nb2O5-doped 3Y-TZP materials sintered by microwave technology

[EN] The purpose of this research is focused on the manufacture and characterization of a partially stabilized zirconia ceramic with 3 mol% of Yttria and doped with .5 and 1.5 mol% of Nb2O5 to analyze the influence of doping, with the purpose of improving the properties before hydrothermal degradation. In the first instance, the microwave sintering process was used for the consolidation of this material, then the physical and mechanical properties were characterized. Together, the results obtained by the conventional sintering process were compared. A low hydrothermal degradation study (LTD) is presented at low temperatures in which possible changes in the mechanical properties of the ceramic materials are analyzed and its influence on the phase transformation that zirconia may present is observed. The mechanical properties were evaluated through hardness, fracture toughness, and Young's modulus tests. Likewise, their density was analyzed, and microstructure was characterized by FESEM. It was found that the microwave-sintered samples at 1200 degrees C exhibited superior properties of toughness than even samples sintered by conventional methods at higher temperatures (1400 degrees C). The sample of 3Y-TZP with 1.5 mol% Nb2O5 sintered by microwave with <.2% of porosity achieved a maximum fracture toughness value around 40% higher than the dense monolithic 3Y-TZP material.Santiago Grisolia program, Grant/Award Number: GRISOLIAP/2018/168; Ministry of Science, Innovation and Universities (Spain), Grant/Award Numbers: RTI2018-099033-B-C32, RYC-2016-20915Guillén-Pineda, RM.; Salvador Moya, MD.; Gutiérrez-González, CF.; Catalá Civera, JM.; Borrell Tomás, MA. (2021). Fabrication and characterization of Nb2O5-doped 3Y-TZP materials sintered by microwave technology. International Journal of Applied Ceramic Technology. 18(6):2033-2044. https://doi.org/10.1111/ijac.138572033204418

Effect on the demand and stock returns: cross-sectional of Big Data and time-series analysis

For reducing the degree of uncertainty caused by constant change in the environment, large, medium or small, private or public organizations must support their decisions in something more than experience or intuition; they must be supported by the development of accurate and reliable forecasts in order to meet the needs in the organization planning tasks. This case study presents a growing company dedicated to the storage of perishable products and incorporates time series forecasting techniques to estimate the volume of storage to foresee the requirements of additional facilities, personnel and materials needed for product mobility

Mejoramiento del parque Juan Aldama - Autoconstrucción de techo verde de bambú en vivienda social, Puerto Vallarta, Jalisco

El proyecto Regeneración socioambiental del río Pitillal en Puerto Vallarta, ha sido desarrollado por los equipos del PAP desde la primavera de 2021 y contempla una metodología que combina la producción social del hábitat (Ortiz. E, 2012) con la autoconstrucción con materiales locales (Comunal, 2019). Se han desarrollado investigaciones para generar diagnósticos, posteriormente se han desarrollados propuestas técnicas que se han validado con los habitantes de la zona. Se busca actualmente pasar a la etapa de la acción participativa, buscando motivar el involucramiento de los actores locales y beneficiarios de las zonas en las que se da el acompañamiento. Se presenta aquí el reporte del proceso de la realización de dos líneas de investigación que dan continuidad a procesos que se originaron en semestres anteriores del PAP en el escenario de Puerto Vallarta:AUTOCONSTRUCCIÓN DE CUBIERTA DE BAMBÚ Y FORESTACIÓN EN PARQUE JUAN ALDAMA y AUTOCONSTRUCCIÓN DE CUBIERTA DE BAMBÚ Y FORESTACIÓN EN AZOTEA DE VIVIENDA EN VALLARTA VILLAS.ITESO, A.C

Tractography passes the test: Results from the diffusion-simulated connectivity (disco) challenge.

Estimating structural connectivity from diffusion-weighted magnetic resonance imaging is a challenging task, partly due to the presence of false-positive connections and the misestimation of connection weights. Building on previous efforts, the MICCAI-CDMRI Diffusion-Simulated Connectivity (DiSCo) challenge was carried out to evaluate state-of-the-art connectivity methods using novel large-scale numerical phantoms. The diffusion signal for the phantoms was obtained from Monte Carlo simulations. The results of the challenge suggest that methods selected by the 14 teams participating in the challenge can provide high correlations between estimated and ground-truth connectivity weights, in complex numerical environments. Additionally, the methods used by the participating teams were able to accurately identify the binary connectivity of the numerical dataset. However, specific false positive and false negative connections were consistently estimated across all methods. Although the challenge dataset doesn't capture the complexity of a real brain, it provided unique data with known macrostructure and microstructure ground-truth properties to facilitate the development of connectivity estimation methods

Week 96 efficacy and safety results of the phase 3, randomized EMERALD trial to evaluate switching from boosted-protease inhibitors plus emtricitabine/tenofovir disoproxil fumarate regimens to the once daily, single-tablet regimen of darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in treatment-experienced, virologically-suppressed adults living with HIV-1

Altres ajuts: This study was sponsored by Janssen.Darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) 800/150/200/10 mg was investigated through 96 weeks in EMERALD (NCT02269917). Virologically-suppressed, HIV-1-positive treatment-experienced adults (previous non-darunavir virologic failure [VF] allowed) were randomized (2:1) to D/C/F/TAF or boosted protease inhibitor (PI) plus emtricitabine/tenofovir-disoproxil-fumarate (F/TDF) over 48 weeks. At week 52 participants in the boosted PI arm were offered switch to D/C/F/TAF (late-switch, 44 weeks D/C/F/TAF exposure). All participants were followed on D/C/F/TAF until week 96. Efficacy endpoints were percentage cumulative protocol-defined virologic rebound (PDVR; confirmed viral load [VL] ≥50 copies/mL) and VL < 50 copies/mL (virologic suppression) and ≥50 copies/mL (VF) (FDA-snapshot analysis). Of 1141 randomized patients, 1080 continued in the extension phase. Few patients had PDVR (D/C/F/TAF: 3.1%, 24/763 cumulative through week 96; late-switch: 2.3%, 8/352 week 52-96). Week 96 virologic suppression was 90.7% (692/763) (D/C/F/TAF) and 93.8% (330/352) (late-switch). VF was 1.2% and 1.7%, respectively. No darunavir, primary PI, tenofovir or emtricitabine resistance-associated mutations were observed post-baseline. No patients discontinued for efficacy-related reasons. Few discontinued due to adverse events (2% D/C/F/TAF arm). Improved renal and bone parameters were maintained in the D/C/F/TAF arm and observed in the late-switch arm, with small increases in total cholesterol/high-density-lipoprotein-cholesterol ratio. A study limitation was the lack of a control arm in the week 96 analysis. Through 96 weeks, D/C/F/TAF resulted in low PDVR rates, high virologic suppression rates, very few VFs, and no resistance development. Late-switch results were consistent with D/C/F/TAF week 48 results. EMERALD week 96 results confirm the efficacy, high genetic barrier to resistance and safety benefits of D/C/F/TAF

Evolution after Anti-TNF Discontinuation in Patients with Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study

OBJECTIVES:The aims of this study were to assess the risk of relapse after discontinuation of anti-tumor necrosis factor (anti-TNF) drugs in patients with inflammatory bowel disease (IBD), to identify the factors associated with relapse, and to evaluate the overcome after retreatment with the same anti-TNF in those who relapsed.METHODS:This was a retrospective, observational, multicenter study. IBD patients who had been treated with anti-TNFs and in whom these drugs were discontinued after clinical remission was achieved were included.RESULTS:A total of 1, 055 patients were included. The incidence rate of relapse was 19% and 17% per patient-year in Crohn''s disease and ulcerative colitis patients, respectively. In both Crohn''s disease and ulcerative colitis patients in deep remission, the incidence rate of relapse was 19% per patient-year. The treatment with adalimumab vs. infliximab (hazard ratio (HR)=1.29; 95% confidence interval (CI)=1.01-1.66), elective discontinuation of anti-TNFs (HR=1.90; 95% CI=1.07-3.37) or discontinuation because of adverse events (HR=2.33; 95% CI=1.27-2.02) vs. a top-down strategy, colonic localization (HR=1.51; 95% CI=1.13-2.02) vs. ileal, and stricturing behavior (HR=1.5; 95% CI=1.09-2.05) vs. inflammatory were associated with a higher risk of relapse in Crohn''s disease patients, whereas treatment with immunomodulators after discontinuation (HR=0.67; 95% CI=0.51-0.87) and age (HR=0.98; 95% CI=0.97-0.99) were protective factors. None of the factors were predictive in ulcerative colitis patients. Retreatment of relapse with the same anti-TNF was effective (80% responded) and safe.CONCLUSIONS:The incidence rate of inflammatory bowel disease relapse after anti-TNF discontinuation is relevant. Some predictive factors of relapse after anti-TNF withdrawal have been identified. Retreatment with the same anti-TNF drug was effective and safe

Cholini (Coleoptera: Curculionidae, Molytinae) depositados na Coleção de Invertebrados do Instituto Nacional de Pesquisas da Amazônia

In Brazilian Amazonia, Cholini (Coleoptera, Curculionidae, Molytinae) is represented by 53 species distributed in seven generaAmeris Dejean, 1821; Cholus Germar, 1824; Homalinotus Sahlberg, 1823; Lobaspis Chevrolat, 1881; Odontoderes Sahlberg, 1823; Ozopherus Pascoe, 1872 and Rhinastus Schoenherr, 1825. This work documents the species of Cholini housed in the Invertebrate Collection of the Instituto Nacional de Pesquisas da Amazônia, Manaus, Brazil and gives the geographical and biological data associated with them. A total of 186 Cholini specimens were identified as belonging to 14 species (13 from Brazilian Amazonia) and five genera (Cholus, Homalinotus, Odontoderes, Ozopherus and Rhinastus). Only 24% of the Cholini species reported from Brazilian Amazonia are actually represented in the INPA collection, underscoring the need for a more systematical collecting based on available biological information. The known geographical distribution was expanded for the following speciesCholus granifer (Chevrolat, 1881) for Brazil; C. pantherinus (Olivier, 1790) for Manaus (Amazonas); Cholus parallelogrammus (Germar, 1824) for Piraquara (Paraná); Homalinotus depressus (Linnaeus, 1758) for lago Janauacá (Amazonas) and rio Tocantins (Pará); H. humeralis (Gyllenhal, 1836) for Novo Airão, Coari (Amazonas) and Porto Velho (Rondônia); H. nodipennis (Chevrolat, 1878) for Carauari, Lábrea (Amazonas) and Ariquemes (Rondônia); H. validus (Olivier, 1790) for rio Araguaia (Brasil), Manaus (Amazonas), rio Tocantins (Pará), Porto Velho and BR 364, Km 130 (Rondônia); Odontoderes carinatus (Guérin-Méneville, 1844) for Manaus (Amazonas); O. spinicollis (Boheman, 1836) for rio Uraricoera (Roraima); and Ozopherus muricatus Pascoe, 1872 for lago Janauacá (Amazonas). Homalinotus humeralis is reported for the first time from "urucuri" palm, Attalea phalerata Mart. ex Spreng.Na Amazônia brasileira, Cholini (Coleoptera, Curculionidae, Molytinae) é representada por 53 espécies, distribuídas em sete gêneros: Ameris Dejean, 1821; Cholus Germar, 1824; Homalinotus Sahlberg, 1823; Lobaspis Chevrolat, 1881; Odontoderes Sahlberg, 1823; Ozopherus Pascoe, 1872 e Rhinastus Schoenherr, 1825. Este trabalho documenta as espécies de Cholini depositadas na Coleção de Invertebrados do Instituto Nacional de Pesquisas da Amazônia, Manaus, Brasil, além de apresentar a distribuição geográfica e informações sobre a biologia dessas espécies. Foram identificados 186 espécimes de Cholini, pertencentes a 14 espécies (13 da Amazônia brasileira) e cinco gêneros (Cholus, Homalinotus, Odontoderes, Ozopherus e Rhinastus). Somente 24% das espécies de Cholini registradas para a Amazônia brasileira estão representadas na coleção do INPA, ressaltando a necessidade de um esforço de coleta sistemático baseado na informação biológica disponível. Foi ampliada a distribuição geográfica conhecida das seguintes espécies: Cholus granifer (Chevrolat, 1881) para Brasil; C. pantherinus (Olivier, 1790) para Manaus (Amazonas); Cholus parallelogrammus (Germar, 1824) para Piraquara (Paraná); Homalinotus depressus (Linnaeus, 1758) para lago Janauacá (Amazonas) e rio Tocantins (Pará); H. humeralis (Gyllenhal, 1836) para Novo Airão, Coari (Amazonas) e Porto Velho (Rondônia); H. nodipennis (Chevrolat, 1878) para Carauari, Lábrea (Amazonas) e Ariquemes (Rondônia); H. validus (Olivier, 1790) para rio Araguaia (Brasil), Manaus (Amazonas), rio Tocantins (Pará), Porto Velho e BR 364, Km 130 (Rondônia); Odontoderes carinatus (Guérin-Méneville, 1844) para Manaus (Amazonas); O. spinicollis (Boheman, 1836) para rio Uraricoera (Roraima) e Ozopherus muricatus Pascoe, 1872 para lago Janauacá (Amazonas). Homalinotus humeralis é associado pela primeira vez com a palmeira urucuri Attalea phalerata Mart. ex Spreng

Crustal recycling by subduction erosion in the central Mexican Volcanic Belt

Recycling of upper plate crust in subduction zones, or ‘subduction erosion’, is a major mechanism of crustal destruction at convergent margins. However, assessing the impact of eroded crust on arc magmas is difficult owing to the compositional similarity between the eroded crust, trench sediment and arc crustal basement that may all contribute to arc magma formation. Here we compare Sr–Nd–Pb–Hf and trace element data of crustal input material to Sr–Nd–Pb–Hf–He–O isotope chemistry of a well-characterized series of olivine-phyric, high-Mg# basalts to dacites in the central Mexican Volcanic Belt (MVB). Basaltic to andesitic magmas crystallize high-Ni olivines that have high mantle-like 3He/4He = 7–8 Ra and high crustal δ18Omelt = +6.3–8.5‰ implying their host magmas to be near-primary melts from a mantle infiltrated by slab-derived crustal components. Remarkably, their Hf–Nd isotope and Nd/Hf trace element systematics rule out the trench sediment as the recycled crust end member, and imply that the coastal and offshore granodiorites are the dominant recycled crust component. Sr–Nd–Pb–Hf isotope modeling shows that the granodiorites control the highly to moderately incompatible elements in the calc-alkaline arc magmas, together with lesser additions of Pb- and Sr-rich fluids from subducted mid-oceanic ridge basalt (MORB)-type altered oceanic crust (AOC). Nd–Hf mass balance suggests that the granodiorite exceeds the flux of the trench sediment by at least 9–10 times, corresponding to a flux of ⩾79–88 km3/km/Myr into the subduction zone. At an estimated thickness of 1500–1700 m, the granodiorite may buoyantly rise as bulk ‘slab diapirs’ into the mantle melt region and impose its trace element signature (e.g., Th/La, Nb/Ta) on the prevalent calc-alkaline arc magmas. Deep slab melting and local recycling of other slab components such as oceanic seamounts further diversify the MVB magmas by producing rare, strongly fractionated high-La magmas and a minor population of high-Nb magmas, respectively. Overall, the central MVB magmas inherit their striking geochemical diversity principally from the slab, thus emphasizing the importance of continental crust recycling in modern solid Earth relative to its new formation in modern subduction zones

Evolution of the use of corticosteroids for the treatment of hospitalised COVID-19 patients in Spain between March and November 2020: SEMI-COVID national registry

Objectives: Since the results of the RECOVERY trial, WHO recommendations about the use of corticosteroids (CTs) in COVID-19 have changed. The aim of the study is to analyse the evolutive use of CTs in Spain during the pandemic to assess the potential influence of new recommendations. Material and methods: A retrospective, descriptive, and observational study was conducted on adults hospitalised due to COVID-19 in Spain who were included in the SEMI-COVID- 19 Registry from March to November 2020. Results: CTs were used in 6053 (36.21%) of the included patients. The patients were older (mean (SD)) (69.6 (14.6) vs. 66.0 (16.8) years; p < 0.001), with hypertension (57.0% vs. 47.7%; p < 0.001), obesity (26.4% vs. 19.3%; p < 0.0001), and multimorbidity prevalence (20.6% vs. 16.1%; p < 0.001). These patients had higher values (mean (95% CI)) of C-reactive protein (CRP) (86 (32.7-160) vs. 49.3 (16-109) mg/dL; p < 0.001), ferritin (791 (393-1534) vs. 470 (236- 996) µg/dL; p < 0.001), D dimer (750 (430-1400) vs. 617 (345-1180) µg/dL; p < 0.001), and lower Sp02/Fi02 (266 (91.1) vs. 301 (101); p < 0.001). Since June 2020, there was an increment in the use of CTs (March vs. September; p < 0.001). Overall, 20% did not receive steroids, and 40% received less than 200 mg accumulated prednisone equivalent dose (APED). Severe patients are treated with higher doses. The mortality benefit was observed in patients with oxygen saturation </=90%. Conclusions: Patients with greater comorbidity, severity, and inflammatory markers were those treated with CTs. In severe patients, there is a trend towards the use of higher doses. The mortality benefit was observed in patients with oxygen saturation </=90%

Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification

The multifactorial likelihood analysis method has demonstrated utility for quantitative assessment of variant pathogenicity for multiple cancer syndrome genes. Independent data types currently incorporated in the model for assessing BRCA1 and BRCA2 variants include clinically calibrated prior probability of pathogenicity based on variant location and bioinformatic prediction of variant effect, co-segregation, family cancer history profile, co-occurrence with a pathogenic variant in the same gene, breast tumor pathology, and case-control information. Research and clinical data for multifactorial likelihood analysis were collated for 1,395 BRCA1/2 predominantly intronic and missense variants, enabling classification based on posterior probability of pathogenicity for 734 variants: 447 variants were classified as (likely) benign, and 94 as (likely) pathogenic; and 248 classifications were new or considerably altered relative to ClinVar submissions. Classifications were compared with information not yet included in the likelihood model, and evidence strengths aligned to those recommended for ACMG/AMP classification codes. Altered mRNA splicing or function relative to known nonpathogenic variant controls were moderately to strongly predictive of variant pathogenicity. Variant absence in population datasets provided supporting evidence for variant pathogenicity. These findings have direct relevance for BRCA1 and BRCA2 variant evaluation, and justify the need for gene-specific calibration of evidence types used for variant classification